Suggestions

Du même auteur

Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC

Archive ouverte | Lucibello, Francesca | CCSD

International audience. Introduction: Pralsetinib is a RET inhibitor found to have antitumor activity in advanced, metastatic, RET fusionpositive NSCLC.Objective: To assess real-world efficacy of pralsetinib and tre...

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study

Archive ouverte | Bilger, Geoffroy | CCSD

International audience. Introduction: Compared with docetaxel, the phase-III trial, ULTIMATE, showed a significant improvement of progression-free survival (PFS) with paclitaxel-bevacizumab combination (PB) as secon...

LIBELULE: a randomized phase III study to evaluate the clinical relevance of early liquid biopsy in patients with suspicious metastatic lung cancer

Archive ouverte | Swalduz, Aurélie | CCSD

International audience

Chargement des enrichissements...